Why sepsis trials fail
- PMID: 8709407
Why sepsis trials fail
Comment in
-
Why sepsis trials fail.JAMA. 1996 Dec 4;276(21):1723. doi: 10.1001/jama.276.21.1723b. JAMA. 1996. PMID: 8940317 No abstract available.
Similar articles
-
[Hypertonic saline and sepsis].Ann Fr Anesth Reanim. 2004 Jun;23(6):563-5. doi: 10.1016/j.annfar.2004.04.008. Ann Fr Anesth Reanim. 2004. PMID: 15234719 French. No abstract available.
-
[Clinical data on the use of selenase in sepsis].Dtsch Med Wochenschr. 2009 Dec;134 Suppl 11:S411-3. doi: 10.1055/s-0029-1243038. Epub 2009 Dec 8. Dtsch Med Wochenschr. 2009. PMID: 19998233 German. No abstract available.
-
HMGB1, a potent proinflammatory cytokine in sepsis.Cytokine. 2010 Aug;51(2):119-26. doi: 10.1016/j.cyto.2010.02.021. Epub 2010 Mar 26. Cytokine. 2010. PMID: 20347329 Review.
-
[Infection and inflammation in sepsis].Vojnosanit Pregl. 2006 Feb;63(2):163-8. doi: 10.2298/vsp0602163s. Vojnosanit Pregl. 2006. PMID: 16502992 Review. Serbian. No abstract available.
-
Should we target blood pressure in sepsis?Crit Care Med. 2010 Oct;38(10 Suppl):S613-9. doi: 10.1097/CCM.0b013e3181f2430c. Crit Care Med. 2010. PMID: 21164405 Review.
Cited by
-
Reduced oxidative tissue damage during endotoxemia in IRAK-1 deficient mice.Mol Immunol. 2012 Apr;50(4):244-52. doi: 10.1016/j.molimm.2012.01.011. Epub 2012 Feb 24. Mol Immunol. 2012. PMID: 22364946 Free PMC article.
-
In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa.Int J Mol Med. 2012 Sep;30(3):455-64. doi: 10.3892/ijmm.2012.1040. Epub 2012 Jun 20. Int J Mol Med. 2012. PMID: 22735858 Free PMC article.
-
Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.Aging Dis. 2011 Dec;2(6):501-11. Epub 2011 Dec 2. Aging Dis. 2011. PMID: 22396897 Free PMC article.
-
Sepsis: from pattern to mechanism and back.Crit Rev Biomed Eng. 2012;40(4):341-51. doi: 10.1615/critrevbiomedeng.v40.i4.80. Crit Rev Biomed Eng. 2012. PMID: 23140124 Free PMC article. Review.
-
Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.Intensive Care Med. 2000 Mar;26 Suppl 2:S170-4. doi: 10.1007/BF02900732. Intensive Care Med. 2000. PMID: 18470714
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical